PTPI: Petros Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PTPI: Petros Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.04
Enterprise Value ($M) 4.40
Book Value ($M) 3.12
Book Value / Share 0.31
Price / Book 0.33
NCAV ($M) -6.85
NCAV / Share -0.68
Price / NCAV -0.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.38

Liquidity (mrq)
Quick Ratio 0.61
Current Ratio 0.85

Balance Sheet (mrq) ($M)
Current Assets 10.72
Assets 20.69
Liabilities 17.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-26 13G Iroquois Capital Management, LLC 9.99 1,405.83
02-13 13G/A Ayrton Capital LLC 6.20 -2.27
11-13 13G/A Intracoastal Capital, Llc 4.99 226.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-31 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 2,951,109 8,069,891 36.57
2025-03-07 7,745,779 20,186,105 38.37
2025-03-06 2,505,091 6,341,998 39.50
2025-03-05 1,277,207 3,609,613 35.38

(click for more detail)

Similar Companies
PRQR – ProQR Therapeutics N.V. PRTG – Portage Biotech Inc.
PTIX – Protagenic Therapeutics, Inc. PULM – Pulmatrix, Inc.
QLGN – Qualigen Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io